1. Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study. Issue 11 (November 2021) Authors: Kelly, Kevin R; Ailawadhi, Sikander; Siegel, David S; Heffner, Leonard T; Somlo, George; Jagannath, Sundar; Zimmerman, Todd M; Munshi, Nikhil C; Madan, Sumit; Chanan-Khan, Asher; Lonial, Sagar; Chandwani, Suraj; Minasyan, Ashot; Ruehle, Markus; Barmaki-Rad, Farima; Abdolzade-Bavil, Afsaneh; Rharb... Journal: Lancet Issue: Volume 8:Issue 11(2021) Page Start: e794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗